Correlation Between Century Therapeutics and Pentair PLC
Can any of the company-specific risk be diversified away by investing in both Century Therapeutics and Pentair PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Century Therapeutics and Pentair PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Century Therapeutics and Pentair PLC, you can compare the effects of market volatilities on Century Therapeutics and Pentair PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Century Therapeutics with a short position of Pentair PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Century Therapeutics and Pentair PLC.
Diversification Opportunities for Century Therapeutics and Pentair PLC
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Century and Pentair is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Century Therapeutics and Pentair PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pentair PLC and Century Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Century Therapeutics are associated (or correlated) with Pentair PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pentair PLC has no effect on the direction of Century Therapeutics i.e., Century Therapeutics and Pentair PLC go up and down completely randomly.
Pair Corralation between Century Therapeutics and Pentair PLC
Given the investment horizon of 90 days Century Therapeutics is expected to under-perform the Pentair PLC. In addition to that, Century Therapeutics is 1.75 times more volatile than Pentair PLC. It trades about -0.61 of its total potential returns per unit of risk. Pentair PLC is currently generating about -0.01 per unit of volatility. If you would invest 9,923 in Pentair PLC on November 9, 2024 and sell it today you would lose (60.00) from holding Pentair PLC or give up 0.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Century Therapeutics vs. Pentair PLC
Performance |
| Timeline |
| Century Therapeutics |
| Pentair PLC |
Century Therapeutics and Pentair PLC Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Century Therapeutics and Pentair PLC
The main advantage of trading using opposite Century Therapeutics and Pentair PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Century Therapeutics position performs unexpectedly, Pentair PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pentair PLC will offset losses from the drop in Pentair PLC's long position.| Century Therapeutics vs. Edgewise Therapeutics | Century Therapeutics vs. C4 Therapeutics | Century Therapeutics vs. Mineralys Therapeutics, Common | Century Therapeutics vs. Cullinan Oncology LLC |
| Pentair PLC vs. Illinois Tool Works | Pentair PLC vs. Parker Hannifin | Pentair PLC vs. Emerson Electric | Pentair PLC vs. Smith AO |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |